Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Pfeffer

Showing results (271-280 of 520) with videos related to

Pageof 52
Sort By:
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2009
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study designHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
European Heart Journal|May 26, 2011
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trialAnne-Catherine Pouleur, Dorit Knappe, Amil M Shah, et al.
European Journal of Heart Failure|October 23, 2010
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarctionAmil M Shah, Hajime Uno, Lars Køber, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2007
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudyGary F Mitchell, Mark E Dunlap, Wayne Warnica, et al.
Journal of the American College of Cardiology|July 16, 2013
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)Chih M Wong, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarctionLisa M Mielniczuk, Gervasio A Lamas, Greg C Flaker, et al.
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
European Heart Journal|February 15, 2011
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunctionScott D Solomon, Sung Hee Shin, Amil Shah, et al.
European Heart Journal|July 19, 2015
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trialPardeep S Jhund, John J V McMurray, Nish Chaturvedi, et al.
Pageof 52

Showing results (271-280 of 520) with videos related to

Sort By:
Pageof 52
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2009
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study designHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
European Heart Journal|May 26, 2011
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trialAnne-Catherine Pouleur, Dorit Knappe, Amil M Shah, et al.
European Journal of Heart Failure|October 23, 2010
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarctionAmil M Shah, Hajime Uno, Lars Køber, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2007
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudyGary F Mitchell, Mark E Dunlap, Wayne Warnica, et al.
Journal of the American College of Cardiology|July 16, 2013
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)Chih M Wong, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 4, 2007
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarctionLisa M Mielniczuk, Gervasio A Lamas, Greg C Flaker, et al.
JAMA|May 29, 2024
Revisiting Race and the Benefit of RAS Blockade in Heart Failure: A Meta-Analysis of Randomized Clinical TrialsLi Shen, Matthew M Y Lee, Pardeep S Jhund, et al.
European Heart Journal|February 15, 2011
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunctionScott D Solomon, Sung Hee Shin, Amil Shah, et al.
European Heart Journal|July 19, 2015
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trialPardeep S Jhund, John J V McMurray, Nish Chaturvedi, et al.
Pageof 52